Rollins School of Public Health | Faculty Profile
Emory Rollins School of Public Health

Abhinav  Goyal

Associate Professor

Jointly Appointed, Epidemiology

Abhinav Goyal, MD, MHS, FACC, FAHA is an academic cardiologist and clinical investigator who is an Associate Professor of Medicine (Division of Cardiology) at the Emory School of Medicine, with a joint appointment in the Department of Epidemiology at Emory Rollins School of Public Health.  Dr. Goyal also serves as the Chief Quality Officer for the Division of Cardiology at Emory Healthcare.  He is responsible for directing all quality-related initiatives in the Division of Cardiology at Emory Healthcare, including providing physician oversight for Emory Hospitals' participation in the American College of Cardiology National Cardiovascular Data Registry (CathPCI, ACTION-Registry GWTG, and ICD Registries); American Heart Association Mission: Lifeline program for patients with acute heart attacks; and The Emory Clinic's quality improvement initiatives pertaining to cardiovascular performance measures.  Dr. Goyal’s research interests include population research investigating the link between diabetes or dysglycemia and cardiovascular disease; quality, health services research, and outcomes research in cardiovascular medicine; cardiovascular clinical trials; and global tobacco control.

 

To learn more about Dr. Goyal's clinical, research, service, and teaching contributions, please click on the "Curriculum Vitae" link below, or visit the link

http://scholar.google.com/citations?user=A5JS8dkAAAAJ

View Resume

Contact Information

1462 Clifton Rd NE , Room 531

Atlanta , GA 30322

Room 531

Phone: 404-727-8758

Fax: 404-727-6495

Email: AGOYAL4@EMORY.EDU

Update Profile Here

Areas of Interest

  • Diabetes
  • Health Outcomes
  • Cardiovascular Diseases
  • Tobacco Control and Prevention

Publications

  • , , Glucose normalization and outcomes in patients hospitalized with acute myocardial infarction – defining the optimal glucose target range., Arch Intern Med, 169, 438-446
  • , , Efficacy and safety of edifoligide, an E2F transcription factor decoy, for the prevention of vein graft failure following coronary artery bypass graft surgery., JAMA, 294, 2446-54
  • , , The burden of cardiovascular disease in the Indian subcontinent. , Indian J Med Res , 124, 235-44
  • , , Insulin therapy in acute coronary syndrome: a current appraisal of completed and ongoing randomized trials with important clinical endpoints., Diabetes Vasc Dis Res, 5, 276-84
  • , , Attained educational level and incident atherothrombotic events in low-and-middle income compared with high-income countries., Circulation, 122, 1167-75
  • , , Predictors of incident heart failure in a large insured population: a one million person-year follow-up study, Circulation: Heart Failure, 3, 698-705
  • , , Piloting a novel algorithm for glucose control in the CCU: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Trial., Diabetes Care, , doi: 10.2337/dc11-0706
  • , , Serum potassium levels and mortality in acute myocardial infarction, JAMA, 307, 157-64
  • , , To view complete list of publications, please click on "View Resume" link above., , ,
  • , , Health system-wide quality programs to improve blood pressure control, JAMA, 310, 695-6
  • , , Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. , Circulation, 120, 2429-2437
  • , , Glucose-insulin-potassium (GIK) therapy in patients with ST-segment elevation myocardial infarction., JAMA, 298, 2399-2405
  • , , Outcomes associated with the use of secondary prevention medications following coronary artery bypass graft surgery., Ann Thorac Surg, 83, 993-1001
  • , , Prognostic significance of the change in glucose in first 24 hours after acute myocardial infarction: results from the CARDINAL study., Eur Heart J, 27, 1289-97
  • , , The relationship between spontaneous and iatrogenic hyperglycemia and mortality in patients hospitalized with acute myocardial infarction., JAMA, 301, 1556-1564